MAM
PLSE icon

Meeder Asset Management’s Pulse Biosciences PLSE Stock Holding History

Meeder Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-186
Closed -$1K – 2367
2020
Q1 		$1K Buy
+186
New +$1.93K ﹤0.01% 2215
2019
Q1 		– Sell
-133
Closed -$2K – 1813
2018
Q4 		$2K Buy
+133
New +$1.61K ﹤0.01% 1583

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Meeder Asset Management's PLSE Position: Q2 2020 in Review

Meeder Asset Management sold out of Pulse Biosciences (PLSE) in Q2 2020, closing a stake of 186 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in PLSE in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q4 2018. 51 funds tracked by Wall St. Rank hold PLSE as of Q2 2020.

  • Meeder Asset Management reported no remaining Pulse Biosciences position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 186 Pulse Biosciences shares in Q2 2020, an estimated $1K.
  • Meeder Asset Management first reported a position in Pulse Biosciences in Q4 2018 and held it in 2 quarters.
  • Meeder Asset Management's Pulse Biosciences position peaked at $2K in Q4 2018.
  • 51 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.